Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 31, 2011PLoS ONEOpen Access

Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition

View Full Paper
Ask AI
Bookmark
Share

Authors

SSSharmila ShankarTulane UniversityDNDara NallThe University of Kansas Cancer CenterSTSu‐Ni TangTexas Tech University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Shankar et al. (2011) studied this question.

synapsesocial.com/papers/6a8002d81024bacc969281b7https://doi.org/10.1371/journal.pone.0016530
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identification of genes differentially expressed in testes containing carcinoma in situ2004 · 57 citations
  2. 2Prospective identification of tumorigenic breast cancer cells2003 · 10,468 citations
  3. 3Cancer Stem Cells and Epithelial-Mesenchymal Transition: Revisiting Minimal Residual Disease2010 · 58 citations
  4. 4Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy2008 · 1,039 citations
  5. 5Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine <i>in vitro</i> and in orthotopic mouse model of human pancreatic cancer2010 · 232 citations